Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 6.55% | |
| Drug Manufacturers - General | 33.37% | 4.21% | |
| Medical Devices | 13.58% | 10.75% | |
| Healthcare Plans | 12.50% | 9.33% | |
| Biotechnology | 10.91% | 4.85% | |
| Diagnostics & Research | 10.84% | 4.15% | |
| Medical Instruments & Supplies | 8.08% | 7.25% | |
| Medical Care Facilities | 3.00% | 11.18% | |
| Drug Manufacturers - Specialty & Generic | 2.65% | 5.10% | |
| Medical Distribution | 2.53% | 7.79% | |
| Health Information Services | 2.43% | 14.96% | |
| Pharmaceutical Retailers | 0.13% | 5.48% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
<= -3
-2
-1
0
1
2
>= 3
Largest Companies in This Sector
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| | 972.57 | 11.23% | | | | Buy | |
| | 637.24 | 7.59% | | | | Strong Buy | |
| | 168.64 | 5.59% | | | | Buy | |
| | 204.90 | 5.07% | | | | Buy | |
| | 123.63 | 3.47% | | | | Buy | |
| | 133.08 | 3.39% | | | | Buy | |
| | 662.36 | 3.36% | | | | Buy | |
| | 629.37 | 3.12% | | | | Buy | |
| | 315.85 | 2.35% | | | | Buy | |
| | 268.88 | 2.35% | | | | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| | 36.396B | 0.09% | | |
| | 18.975B | 0.10% | | |
| | 6.463B | 0.45% | | |
| | 6.369B | 0.35% | | |
| | 4.4B | 0.40% | |
Mutual Fund Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| | 40.511B | 0.30% | | |
| | 40.511B | 0.30% | | |
| | 18.975B | 0.10% | | |
| | 13.014B | 0.80% | | |
| | 13.014B | 0.80% | |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
Analyst Report: Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
RatingPrice TargetAnalyst Report: Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
RatingPrice TargetAnalyst Report: Coloplast A/S
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
RatingPrice TargetAnalyst Report: McKesson Corporation
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
RatingPrice Target




















